| Net Sales | 209.3M |
| Cost of products sold | 146.2M |
| Gross Profit | 63.1M |
| Selling expense | 6M |
| Research expense | 4.2M |
| General expense | 20.8M |
| Total nonmanufacturing expenses | 31M |
| Restructuring and impairment expense | 1.3M |
| Operating Profit | 30.8M |
| Interest expense | 3.9M |
| Other income (expense), net | 700K |
| Income from Continuing Operations before Income Taxes and Income from Equity Affiliates | 27.6M |
| Provision for income taxes | 10.7M |
| Income from equity affiliates | |
| Income from Continuing Operations | 18.7M |
| Loss from Discontinued Operations | 0 |
| Net Income | 18.7M |
| Income per share from continuing operations | 0.62 |
| Loss per share from discontinued operations | 0 |
| Net income per share - basic | 0.62 |
| Income per share from continuing operations | 0.61 |
| Loss per share from discontinued operations | 0 |
| Net income per share - diluted | 0.61 |
| Cash Dividends Declared Per Share | |
| Basic | 30.32M |
| Diluted | 30.46M |